Document is current
Any future updates will be listed below
-
Authors
Riotto, Eleonora https://orcid.org/0000-0002-3593-2516
Lamanna, Francesca https://orcid.org/0009-0007-7956-6056
Khan, Adnan H. https://orcid.org/0000-0001-8153-8002
Thottarath, Sridevi
Khalid, Hagar https://orcid.org/0000-0002-5311-4015
Chandak, Swati https://orcid.org/0000-0001-8255-6253
Bennett, Jessica
Hill, Sarah
Faes, Livia https://orcid.org/0000-0002-4159-3960
Fu, Dun Jack https://orcid.org/0000-0003-2852-6912
- License Information
-
More Information
Article History
Received: 8 November 2025
Revised: 5 December 2025
Accepted: 23 January 2026
First Online: 4 February 2026
Competing interests
: DJF: Consulting fees and/or research support from AbbVie, Allergan, Apellis, Boehringer Ingelheim, Galimedix, Google Health, NIHR, Wellcome Trust, Roche. Livia Faes has received research support from Bayer AG, F. Hoffmann-La Roche AG and AbbVie, and meetings and travel support from Apellis Pharmaceuticals Inc. LF and DJF are members of the Eye editorial board. The remaining authors report no conflicts of interest.
